Interleukin-2-inducible T-cell kinase (ITK) targeting by BMS-509744 does not affect cell viability in T-cell prolymphocytic leukemia (T-PLL).

• Authors: Sabine Dondorf, Alexandra Schrader, Marco Herling
• Journal: The Journal of biological chemistry (J Biol Chem) Vol. 290 Issue 16 Pg. 10568-9 (Apr 17 2015) ISSN: 1083-351X [Electronic] United States
• PMID: 25888568 (Publication Type: Letter, Comment)

Chemical References

• Benzimidazoles
• Protein Kinase Inhibitors
• Protein-Tyrosine Kinases

Topics

• Benzimidazoles (administration & dosage)
• Humans
• Protein Kinase Inhibitors (administration & dosage)
• Protein-Tyrosine Kinases (metabolism)
• T-Lymphocytes (drug effects)